0001209191-23-041799.txt : 20230707 0001209191-23-041799.hdr.sgml : 20230707 20230707162722 ACCESSION NUMBER: 0001209191-23-041799 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230706 FILED AS OF DATE: 20230707 DATE AS OF CHANGE: 20230707 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McCullough James Renwick CENTRAL INDEX KEY: 0001974146 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39387 FILM NUMBER: 231077069 MAIL ADDRESS: STREET 1: C/O RENALYTIX PLC STREET 2: FINSGATE, 5-7 CRANWOOD STREET CITY: LONDON STATE: X0 ZIP: EC1V 9EE ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Renalytix plc CENTRAL INDEX KEY: 0001811115 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: FINSGATE STREET 2: 5-7 CRANWOOD STREET CITY: LONDON STATE: X0 ZIP: EC1V 9EE BUSINESS PHONE: 44 29 2071 0570 MAIL ADDRESS: STREET 1: FINSGATE STREET 2: 5-7 CRANWOOD STREET CITY: LONDON STATE: X0 ZIP: EC1V 9EE FORMER COMPANY: FORMER CONFORMED NAME: Renalytix AI plc DATE OF NAME CHANGE: 20200430 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-07-06 0 0001811115 Renalytix plc RNLX 0001974146 McCullough James Renwick C/O RENALYTIX PLC FINSGATE, 5-7 CRANWOOD STREET LONDON X0 EC1V 9EE UNITED KINGDOM 1 1 0 0 Chief Executive Officer 0 Employee Stock Option (right to buy) 2023-07-06 4 A 0 875017 0.00 A 2033-07-05 Ordinary Shares 875017 875017 D The exercise price is 1.025 pounds sterling. The U.S. dollar equivalent of the exercise price is $1.301 using the Bank of England rate as of July 6, 2023 (1.00 pound sterling = $1.269). One twelfth (1/12th) of the shares subject to the option award shall vest in equal quarterly installments commencing on October 6, 2023, subject to the Reporting Person's continuous service. /s/ Katie Kazem, Attorney-in-Fact 2023-07-07